ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record9 judgments2 judges (the rules as one: Rule based)1 record change seen
Model not recordedRule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05144698RAPA-201 Therapy of SolidTumorsRapa Therapeutics LLCPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termHead and Neck NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseSquamous Cell Carcinoma of …The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termMelanomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termEsophageal Squamous Cell Ca…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSAutologous rapamycin-resist…Entry “RAPA-201 Rapamycin Resistant T…›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedPembrolizumabEntry “Pembrolizumab (PD-1 Blocking A…›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Autologous rapamycin-resistant TH1/TC1 cells RAPA-201

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “RAPA-201 Rapamycin Resistant T Cells”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1Autologous rapamycin-resistant TH1/TC1 cells RAPA-201A model not recordedTestedCurrent
Nov 1PembrolizumabA model not recordedBackgroundCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Head and Neck NeoplasmsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Squamous Cell Carcinoma of Head and NeckRule based · condition-kind ruleFinest filed termCurrent
Nov 14MelanomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Esophageal Squamous Cell CarcinomaRule based · condition-kind ruleFinest filed termCurrent
Nov 18Autologous rapamycin-resistant TH1/TC1 cells RAPA-201Rule based · role ruleTestedAgrees
Nov 18PembrolizumabRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.